506938 — Kappac Pharma Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Kappac Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2012 March 31st | 2013 March 31st | 2014 March 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Preliminary | Preliminary |
| Net Income/Starting Line | -0.613 | -0.832 | -0.831 | -0.153 | -22 |
| Depreciation | |||||
| Non-Cash Items | — | — | — | 0 | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.097 | -42.8 | 42.8 | 7.2 | -5.31 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.71 | -43.6 | 41.9 | 7.05 | -27.3 |
| Capital Expenditures | — | — | — | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -30.2 | -54.2 | 0 | 13.2 | 27.3 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -30.2 | -54.2 | 0 | 13.2 | 27.3 |
| Financing Cash Flow Items | 0.341 | 129 | 0.341 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 30.9 | 98.2 | 5.2 | 6.1 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.024 | 0.32 | 47.1 | 26.3 | -0.002 |